NCT07326982

Brief Summary

This randomized, double-blind prospective trial investigates whether ultrasound-guided interfascial hydrodissection using 10% dextrose is more effective than dry needling in treating gluteal myofascial pain coexisting with piriformis syndrome. Following diagnostic piriformis injection response, eligible patients will be randomized into two treatment arms and followed at 1 hour, 1 week, 1 month, and 3 months. The primary hypothesis is that interfascial hydrodissection will provide superior long-term analgesic outcomes due to fascial separation, neuromodulation, and nociceptor suppression.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for not_applicable

Timeline
5mo left

Started Mar 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress23%
Mar 2026Sep 2026

First Submitted

Initial submission to the registry

December 24, 2025

Completed
15 days until next milestone

First Posted

Study publicly available on registry

January 8, 2026

Completed
3 months until next milestone

Study Start

First participant enrolled

March 26, 2026

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 28, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 28, 2026

Last Updated

March 13, 2026

Status Verified

March 1, 2026

Enrollment Period

3 months

First QC Date

December 24, 2025

Last Update Submit

March 11, 2026

Conditions

Keywords

Interfascial hydrodissectionGluteal painUltrasound-guided injection

Outcome Measures

Primary Outcomes (1)

  • Pain Intensity Assessed by Numeric Rating Scale

    Pain intensity is assessed using the Numeric Rating Scale (NRS, 0-10) for pain at rest, during activity, at night, while standing, sitting, lying down, and for overall pain.

    3 months after the intervention

Secondary Outcomes (2)

  • Pain Intensity Assessed by Numeric Rating Scale

    1 week after the intervention

  • Pain Intensity Assessed by Numeric Rating Scale

    1 month after the intervention

Study Arms (2)

Ultrasound-Guided Interfascial Hydrodissection

EXPERIMENTAL

Ultrasound-guided interfascial hydrodissection is performed in the interfascial space between the gluteus maximus and piriformis muscles.

Procedure: Ultrasound-Guided Interfascial Hydrodissection

Ultrasound-guided gluteus maximus dry needling

ACTIVE COMPARATOR

Participants receive ultrasound-guided dry needling applied to the gluteus maximus muscle.

Procedure: Ultrasound-Guided Gluteus Maximus Dry Needling

Interventions

Ultrasound-guided interfascial hydrodissection is performed in the interfascial plane between the gluteus maximus and piriformis muscles.

Ultrasound-Guided Interfascial Hydrodissection

Ultrasound-guided dry needling is performed on the gluteus maximus muscle without fluid administration.

Ultrasound-guided gluteus maximus dry needling

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged 18 to 75 years
  • Buttock pain with or without radiation to the lower extremity
  • Ability to understand and provide written informed consent

You may not qualify if:

  • Active lumbar radiculopathy
  • History of hip joint pathology or prior hip surgery
  • Previous injection or dry needling treatment to the gluteal region within the last 3 months
  • Coagulation disorders or use of anticoagulant therapy
  • Pregnancy
  • Local infection at the injection site
  • Inability to complete the study protocol or attend follow-up visits.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine

Istanbul, Istanbul, Turkey (Türkiye)

Location

Related Publications (3)

  • Tantanatip A, Patisumpitawong W, Lee S. Comparison of the Effects of Physiologic Saline Interfascial and Lidocaine Trigger Point Injections in Treatment of Myofascial Pain Syndrome: A Double-Blind Randomized Controlled Trial. Arch Rehabil Res Clin Transl. 2021 Mar 9;3(2):100119. doi: 10.1016/j.arrct.2021.100119. eCollection 2021 Jun.

  • Misirlioglu TO, Akgun K, Palamar D, Erden MG, Erbilir T. Piriformis syndrome: comparison of the effectiveness of local anesthetic and corticosteroid injections: a double-blinded, randomized controlled study. Pain Physician. 2015 Mar-Apr;18(2):163-71.

  • Kaga M, Ueda T. Effectiveness of Hydro-Dissection of the Piriformis Muscle Plus Low-Dose Local Anesthetic Injection for Piriformis Syndrome: A Report of 2 Cases. Am J Case Rep. 2022 Feb 6;23:e935346. doi: 10.12659/AJCR.935346.

MeSH Terms

Conditions

Piriformis Muscle Syndrome

Condition Hierarchy (Ancestors)

Sciatic NeuropathyMononeuropathiesPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesNerve Compression SyndromesNeuralgiaPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPelvic Pain

Central Study Contacts

Busra Nur Aslantas, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident Physician, Physical Medicine and Rehabilitation Department

Study Record Dates

First Submitted

December 24, 2025

First Posted

January 8, 2026

Study Start

March 26, 2026

Primary Completion (Estimated)

June 28, 2026

Study Completion (Estimated)

September 28, 2026

Last Updated

March 13, 2026

Record last verified: 2026-03

Locations